ObsEva SA (NASDAQ: OBSV) disclosed that it has planned an H.C. Wainwright Global Life Sciences Conference. The conference is scheduled to take place from March 9-10, 2021. The management of the firm will offer a corporate update and engage in one-on-one investor meetings.
The presentation will be available on-demand through the H.C. Wainwright conference portal, beginning at 7 a.m. EST on Tuesday, March 9, 2021. OBSV is a biopharmaceutical firm creating and marketing novel therapies to enhance women’s reproductive health.
Shares if ObsEva SA (NASDAQ: OBSV) last closed at $3.90, in a 52-week range of $1.63 to $6.30. It has surged 139.26% during the past 52-week of low range and -38.10% from its 52-weeks of high range.
If we look at the recent analyst rating OBSV, JP Morgan has started coverage on OBSV shares with an Underweight rating. Looking at the profitability, it has ROA, and ROE of -93.20%, and -256.20%, respectively. ObsEva has a total market capitalization of $217.50 million at the time of writing.